2024-01-012024-12-312024-12-31false09754430SIRONA MEDICAL LTD2025-09-25falseiso4217:GBPxbrli:pure097544302023-12-31097544302024-12-31097544302024-01-012024-12-31097544302022-12-31097544302023-12-31097544302023-01-012023-12-3109754430bus:SmallEntities2024-01-012024-12-3109754430bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3109754430bus:FullAccounts2024-01-012024-12-3109754430bus:PrivateLimitedCompanyLtd2024-01-012024-12-3109754430core:WithinOneYear2024-12-3109754430core:AfterOneYear2024-12-3109754430core:WithinOneYear2023-12-3109754430core:AfterOneYear2023-12-3109754430core:ShareCapital2024-12-3109754430core:SharePremium2024-12-3109754430core:RevaluationReserve2024-12-3109754430core:OtherReservesSubtotal2024-12-3109754430core:RetainedEarningsAccumulatedLosses2024-12-3109754430core:ShareCapital2023-12-3109754430core:SharePremium2023-12-3109754430core:RevaluationReserve2023-12-3109754430core:OtherReservesSubtotal2023-12-3109754430core:RetainedEarningsAccumulatedLosses2023-12-3109754430core:LandBuildings2024-12-3109754430core:PlantMachinery2024-12-3109754430core:Vehicles2024-12-3109754430core:FurnitureFittings2024-12-3109754430core:OfficeEquipment2024-12-3109754430core:NetGoodwill2024-12-3109754430core:IntangibleAssetsOtherThanGoodwill2024-12-3109754430core:ListedExchangeTraded2024-12-3109754430core:UnlistedNon-exchangeTraded2024-12-3109754430core:LandBuildings2023-12-3109754430core:PlantMachinery2023-12-3109754430core:Vehicles2023-12-3109754430core:FurnitureFittings2023-12-3109754430core:OfficeEquipment2023-12-3109754430core:NetGoodwill2023-12-3109754430core:IntangibleAssetsOtherThanGoodwill2023-12-3109754430core:ListedExchangeTraded2023-12-3109754430core:UnlistedNon-exchangeTraded2023-12-3109754430core:LandBuildings2024-01-012024-12-3109754430core:PlantMachinery2024-01-012024-12-3109754430core:Vehicles2024-01-012024-12-3109754430core:FurnitureFittings2024-01-012024-12-3109754430core:OfficeEquipment2024-01-012024-12-3109754430core:NetGoodwill2024-01-012024-12-3109754430core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109754430core:ListedExchangeTraded2024-01-012024-12-3109754430core:UnlistedNon-exchangeTraded2024-01-012024-12-3109754430core:MoreThanFiveYears2024-01-012024-12-3109754430core:Non-currentFinancialInstruments2024-12-3109754430core:Non-currentFinancialInstruments2023-12-3109754430dpl:CostSales2024-01-012024-12-3109754430dpl:DistributionCosts2024-01-012024-12-3109754430core:LandBuildings2024-01-012024-12-3109754430core:PlantMachinery2024-01-012024-12-3109754430core:Vehicles2024-01-012024-12-3109754430core:FurnitureFittings2024-01-012024-12-3109754430core:OfficeEquipment2024-01-012024-12-3109754430dpl:AdministrativeExpenses2024-01-012024-12-3109754430core:NetGoodwill2024-01-012024-12-3109754430core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3109754430dpl:GroupUndertakings2024-01-012024-12-3109754430dpl:ParticipatingInterests2024-01-012024-12-3109754430dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3109754430core:ListedExchangeTraded2024-01-012024-12-3109754430dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3109754430core:UnlistedNon-exchangeTraded2024-01-012024-12-3109754430dpl:CostSales2023-01-012023-12-3109754430dpl:DistributionCosts2023-01-012023-12-3109754430core:LandBuildings2023-01-012023-12-3109754430core:PlantMachinery2023-01-012023-12-3109754430core:Vehicles2023-01-012023-12-3109754430core:FurnitureFittings2023-01-012023-12-3109754430core:OfficeEquipment2023-01-012023-12-3109754430dpl:AdministrativeExpenses2023-01-012023-12-3109754430core:NetGoodwill2023-01-012023-12-3109754430core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3109754430dpl:GroupUndertakings2023-01-012023-12-3109754430dpl:ParticipatingInterests2023-01-012023-12-3109754430dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3109754430core:ListedExchangeTraded2023-01-012023-12-3109754430dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3109754430core:UnlistedNon-exchangeTraded2023-01-012023-12-3109754430core:NetGoodwill2024-12-3109754430core:IntangibleAssetsOtherThanGoodwill2024-12-3109754430core:LandBuildings2024-12-3109754430core:PlantMachinery2024-12-3109754430core:Vehicles2024-12-3109754430core:FurnitureFittings2024-12-3109754430core:OfficeEquipment2024-12-3109754430core:AfterOneYear2024-12-3109754430core:WithinOneYear2024-12-3109754430core:ListedExchangeTraded2024-12-3109754430core:UnlistedNon-exchangeTraded2024-12-3109754430core:ShareCapital2024-12-3109754430core:SharePremium2024-12-3109754430core:RevaluationReserve2024-12-3109754430core:OtherReservesSubtotal2024-12-3109754430core:RetainedEarningsAccumulatedLosses2024-12-3109754430core:NetGoodwill2023-12-3109754430core:IntangibleAssetsOtherThanGoodwill2023-12-3109754430core:LandBuildings2023-12-3109754430core:PlantMachinery2023-12-3109754430core:Vehicles2023-12-3109754430core:FurnitureFittings2023-12-3109754430core:OfficeEquipment2023-12-3109754430core:AfterOneYear2023-12-3109754430core:WithinOneYear2023-12-3109754430core:ListedExchangeTraded2023-12-3109754430core:UnlistedNon-exchangeTraded2023-12-3109754430core:ShareCapital2023-12-3109754430core:SharePremium2023-12-3109754430core:RevaluationReserve2023-12-3109754430core:OtherReservesSubtotal2023-12-3109754430core:RetainedEarningsAccumulatedLosses2023-12-3109754430core:NetGoodwill2022-12-3109754430core:IntangibleAssetsOtherThanGoodwill2022-12-3109754430core:LandBuildings2022-12-3109754430core:PlantMachinery2022-12-3109754430core:Vehicles2022-12-3109754430core:FurnitureFittings2022-12-3109754430core:OfficeEquipment2022-12-3109754430core:AfterOneYear2022-12-3109754430core:WithinOneYear2022-12-3109754430core:ListedExchangeTraded2022-12-3109754430core:UnlistedNon-exchangeTraded2022-12-3109754430core:ShareCapital2022-12-3109754430core:SharePremium2022-12-3109754430core:RevaluationReserve2022-12-3109754430core:OtherReservesSubtotal2022-12-3109754430core:RetainedEarningsAccumulatedLosses2022-12-3109754430core:AfterOneYear2024-01-012024-12-3109754430core:WithinOneYear2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3109754430core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3109754430core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3109754430core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3109754430core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3109754430core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3109754430bus:Director12024-01-012024-12-3109754430bus:Director22024-01-012024-12-31

SIRONA MEDICAL LTD

Registered Number
09754430
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

SIRONA MEDICAL LTD
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

Mark Burrell
Natasha Sullivan

Registered Address

Weston House Allen House Business Centre
The Maltings,Station Road
Sawbridgeworth
CM21 9FP

Registered Number

09754430 (England and Wales)
SIRONA MEDICAL LTD
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets3111,432138,755
111,432138,755
Current assets
Debtors41,851,7201,482,560
Cash at bank and on hand-28,251
1,851,7201,510,811
Creditors amounts falling due within one year5(2,265,516)(1,993,855)
Net current assets (liabilities)(413,796)(483,044)
Total assets less current liabilities(302,364)(344,289)
Net assets(302,364)(344,289)
Capital and reserves
Called up share capital300300
Profit and loss account(302,664)(344,589)
Shareholders' funds(302,364)(344,289)
The financial statements were approved and authorised for issue by the Board of Directors on 25 September 2025, and are signed on its behalf by:
Mark Burrell
Director
Registered Company No. 09754430
SIRONA MEDICAL LTD
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Defined contribution pension plan
Contributions to defined contribution plans are expensed in the period to which they relate.
Tangible fixed assets and depreciation
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

Reducing balance (%)Straight line (years)
Plant and machinery-7
Vehicles20-
Office Equipment-4
2.Average number of employees

20242023
Average number of employees during the year2225
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 January 24176,41629,2684,272209,956
At 31 December 24176,41629,2684,272209,956
Depreciation and impairment
At 01 January 2457,06311,2992,83971,201
Charge for year23,7743,59353827,905
Other adjustments--(582)(582)
At 31 December 2480,83714,8922,79598,524
Net book value
At 31 December 2495,57914,3761,477111,432
At 31 December 23119,35317,9691,433138,755
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables959,618700,070
Other debtors833,967700,673
Prepayments and accrued income2,96126,643
Deferred tax asset, debtors55,17455,174
Total1,851,7201,482,560
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables174,950170,735
Bank borrowings and overdrafts1,145,711956,038
Taxation and social security572,073434,640
Other creditors355,383349,819
Accrued liabilities and deferred income17,39982,623
Total2,265,5161,993,855